-Livemint.com Govt plans to?help firms revamp manufacturing units,?refurbish machinery,?ensure subsidized power in bid to produce drugs such as penicillin at competitive rates New Delhi: The Department of Pharmaceuticals (DoP), during a meeting on Wednesday, urged pharma companies to strive for self-sufficiency in critical drugs like penicillin, rifampicin and insulin, in a sign of government concern over India’s dependence on Chinese imports. A large number of so-called active pharmaceutical ingredients (APIs), or bulk drugs,...

-The Hindu Doctors’ objections to prescribing medicines by generic names fly in the face of a recent report on substandard drugs In a surprise move on April 17, Prime Minister Narendra Modi announced that his government will soon make it mandatory for doctors to prescribe medicines by generic names. The decision was to ensure drug prices remain affordable and patients get a wider bouquet of options instead of being forced to...

-Outlook The structural basis is being laid out for future authoritarianism at the behest of foreign biometric and surveillance technology What distinguishes Barack Obama and David Cameron from Narendra Modi? Obama and Cameron oppose biometric identification but Modi supports it. On 11 May 2005 in the US, the Real ID Act for a national ID was rushed through US Congress and the US Senate with utmost urgency, a legacy of George Bush...

-AP New Delhi: Doctors Without Borders has challenged pfizer’s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations. The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging pfizer’s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine. If pfizer is...

-The Telegraph New Delhi: International humanitarian agency Medecins Sans Frontieres has filed an application to block US pharmaceutical company pfizer from obtaining a patent in India for a vaccine against pneumonia and allow Indian vaccine manufacturers to make low-cost versions. The patent opposition moved by MSF has claimed that pfizer's patent application, which describes methods of conjugating 13 serotypes (strains) of the bacterium Streptococcus pneumoniae into a single carrier vaccine, does not...